This study provides evidence that elevated NLRP3/IL‐1β expression promoted the progression of oxaliplatin‐resistant HCC by inducing PD‐L1 upregulation as well as recruitment of PMN‐MDSCs. The gene discussed is IL1B; the disease is hepatocellular carcinoma.